CAAR T-cell therapy offers a more targeted route for neurological autoimmune diseases

Researchers astatine DZNE and Charité—Universitätsmedizin Berlin are moving connected a targeted therapy for neurological autoimmune diseases. So far, they person successfully tested their attack successful rodent studies involving 2 specified conditions. Their conception is based connected deliberately modified immune cells, alleged CAAR T cells, designed to destruct lone the immune cells liable for causing disease.